Cancer Treat Res Commun 2020 21;25:100246. Epub 2020 Nov 21.
Juravinski Cancer Centre, 699 Concession St, Hamilton, ON, L8V 5C2, Canada; McMaster University, 1280 Main St W, Hamilton, ON, L8S 4L8, Canada.
Background: To determine if synchronous extrapulmonary malignancies in early stage lung cancer impact survival and cost of care in the current era of improved therapies and diagnostics.
Methods: Patients with stage I and II lung cancer were identified from the Ontario Cancer Registry and prognostic factors were obtained from provincial health administrative databases. Synchronous extrapulmonary malignancies were defined as those detected within 6 months from diagnosis of the lung primary. Read More